TREATMENT FOR DEPRESSION & CHRONIC PAIN | OUR BLOG
WELCOME TO OUR KETAMINE TREATMENT CENTER’S BLOG
Our blog covers a variety of topics, ranging from news about ketamine research, new depression treatments, chronic pain management, and more. Be sure to subscribe to receive our monthly e-Newsletter so you never miss a blog post!
FEATURED MEDIA
Suicidal Depressed Man Says Ketamine Saved His Life
First-Hand Testimonial from a Ketamine Patient
Spravato is FDA-Approved…and Here’s What You Need to Know
The recent FDA approval of the use of esketamine for treatment-resistant depression means many Americans suffering will soon find relief. The drug, Spravato, was approved for patients who have failed to respond at all to at least two other antidepressant medications. After years of clinical trials, the decision to officially approve Spravato took a month before a panel of experts voted in favor of the new treatment. Since treatment-resistant depression plagues so many among us, this new treatment has generated tremendous hope for depression sufferers, their loved ones, and their mental health clinicians.
Depression and Suicide in Young Adults: The Role of Social Media
Depression is a mental disorder that affects 350 million people world wide. According to a medical paper published by Louisiana State University Health Sciences Center, people in the United States 18 years and older make up 4.6% of those 350 million. The study, which surveyed 600,000—or 0.1836%—of the US population, concluded that those who spend more than 6 hours in front of a screen were at a greater risk for depression.
The Impending FDA Approval of Esketamine and What It Means for Depression Treatment
Since it was developed in 2016, we’ve blogged several times about esketamine—the isomer of ketamine being developed by Janssen Pharmaceuticals, designed to rapidly alleviate the symptoms of treatment-resistant depression. Esketamine, which will be administered intranasally, was granted breakthrough medication status by the FDA and fast-tracked for approval. And the time for approval is here.
The Discovery of Hope: How Ketamine for Depression Came to Be
Over the past several years, ketamine has received a growing amount of media attention. As a treatment for depression, no other medication has shown this much promise since Prozac was discovered in the 1980s. Ketamine has been hailed as “miraculous,” and a “wonder drug,” alleviating depressive symptoms in up to 70% of patients…even those who failed to respond to depression treatment after depression treatment. What’s even more spectacular is the speed in which ketamine works—patients know whether ketamine will work for them after only 1-2 infusions.
Predicting Postpartum Depression: 4 Factors to Determine Risk & the Severity of Symptoms
For many women, giving birth is the most joyous event of their lives. But, every year, for more than 3 million women in the U.S., child birth results in the development of postpartum depression—and it can be devastating for mother and child alike. Most cases of postpartum depression are resolved within a matter of months, with such treatments as talk therapy, antidepressants, and ketamine infusions. However, some cases of postpartum depression can worsen in time, ultimately increasing the mother’s risk for developing chronic, severe depression.
Non-Pharmacological Solutions for Treatment-Resistant Depression
There is no one-size-fits-all solution for depression. Even though 17% of people will suffer from depression over the course of their lives, modern medicine is still searching for a comprehensive solution. Traditional antidepressant medications are the first line of treatment for depression, though they are only effective for about 40-70% of patients, depending on what source you quote. In recent years, ketamine infusions have emerged as one of the most effective depression treatment available, offering hope for even the most debilitating cases of depression and providing relief to 70% of patients. Inspired by the way ketamine works to treat depression, several pharmaceutical companies are well underway developing new medications that may revolutionize the way we treat this mental health disorder.
The Impact of Depression & Anxiety on Physical Health
The importance of diagnosing and treating mental health disorders is incontestable: with the country’s suicide rate growing at a faster rate than ever—and with a number of celebrity suicides bringing much-needed awareness to the matter—there is no argument that mental wellbeing is an important health concern that deserves our attention and care. However, the physical implications of depression and anxiety are much less talked about—even though a new study shows that they can be as severe as the health concerns caused by obesity or smoking.
Ketamine for Depression: One of the Top Mental Health Discoveries of 2018
As one of Colorado’s leading ketamine clinics, we see first-hand the impact that mental health disorders can have on an individual. We see the pain that prevents a patient from engaging in their favorite hobbies or activities, or that keeps them home in bed rather than at the office, or that lets the dishes pile up in the sink day after day because they just can’t bring themselves to perform even the most mundane of household tasks.
ANXIOUS FOR THE HOLIDAYS: THE IMPACT OF THE HOLIDAY SEASON ON ANXIETY & DEPRESSION
The holiday season evokes something different in everyone. Some people experience a childlike elation, enjoying the well-wishes and whimsy of the season. Others look forward to time spent with family, the freedom to check out of work and surround themselves with those they love. However, for many people, the holidays are a major trigger for anxiety and depression.
Innovations in PTSD Treatment: PTSD Patients May Find Hope in MDMA
For those suffering from PTSD, traditional treatments oftentimes fall short when it comes to alleviating symptoms. Antidepressants are effective in only about 40 percent of patients, and benzodiazepines—while commonly prescribed as a treatment for PTSD may actually worsen symptoms. A study recently published in the Journal of Clinical Psychiatry revealed that PTSD patients who were prescribed benzodiazepines were almost twice as likely to attempt suicide. It goes without saying that PTSD patients need and deserve a more effective suite of treatment options.
CONTACT OUR TEAM
Learn more about ketamine treatment for eating disorders and other mental health conditions, and find out if you or a loved one is a candidate.
Contact Us »
CONTACT VITALITAS DENVER
Complete the brief form below and a member of our team will contact you to answer your questions, address any concerns you may have, and point you in the direction of health & wellbeing.
CALL OR EMAIL US
phone: (720) 724-8075
fax: (720) 306-5383
VISIT OUR KETAMINE CLINICS
LITTLETON, CO KETAMINE CLINIC
26 West Dry Creek Circle; Suite 200
Littleton, CO 80120
HOURS:
Monday: 8:30 am - 4:00pm
Thursday: 12:00 pm - 8:00 pm
Friday: 9:00am - 3:00 pm
Saturday: 9:00am - 3:00 pm
WESTMINSTER, CO KETAMINE CLINIC
12110 North Pecos St; Suite 160
Westminster, CO 80234
HOURS:
Tuesday: 12:00 pm - 8:00 pm
Wednesday: 12:00 pm - 8:00 pm
Friday: 12:00 pm - 8:00 pm
GET SOCIAL WITH US
Proud Members of
Proud Supporters of
